Turning the Page; A Promising FutureLOS ANGELES, April 03, 2023 (GLOBE NEWSWIRE) (NASDAQ: ENOB) Accelerated Pre-Investigational New Drug (Pre-IND) submission to the US Food and Drug Administration
Turning the Page; A Promising FutureLOS ANGELES, April 03, 2023 Accelerated Pre-Investigational New Drug submission to the US Food and Drug Administration for potential cancer. | April 3, 2023